Midodrine

Basic Midodrine Information

• INN (International Nonproprietary Name): Metformin

• Brand Names Available In United Kingdom: Sukkarto, Bolamyn, Metabet

• ATC Code: A10BA02

• Forms & Dosages: 250mg, 500mg, 850mg, 1000mg tablets (immediate and sustained release) and oral solutions — not specified for midodrine in raw data

• Manufacturers In United Kingdom: Merck (Glucophage), Teva, Sandoz, Actavis, Sun Pharma, Dr. Reddy’s, Mylan, Zentiva, Terapia Ranbaxy (not specified which manufacture midodrine)

• Registration Status In United Kingdom: Approved and registered for use in many countries; prescription-only status commonly applied (check local MHRA listings)

• OTC / Rx Classification: Prescription-only (Rx) medicine in most countries

Pharmacy Context & Demand

Patients come in asking, “Can something stop me feeling faint when I stand up?”

Midodrine is used as a prescription vasopressor for symptomatic orthostatic hypotension, so pharmacists see demand for fast symptom relief like less dizziness and fewer falls.

Waiting times for GP appointments or NHS specialist referrals can be long, which pushes some patients to enquire about private prescribing and online clinics.

Electronic Prescription Service (EPS) speeds dispensing to familiar chains such as Boots, LloydsPharmacy and Superdrug when a prescription is in place.

Price sensitivity is common and shoppers frequently compare NHS prescription routes with private supply and online fulfilment options.

Patients tell pharmacists they want clear dosing instructions, standing and sitting precautions, and quick access in case symptoms worsen.

Typical patient priorities include rapid symptom relief, trustworthy counselling, clear dosing charts and safe supply routes through NHS or private prescribers.

Typical Patient Journeys & Lived Experience

A common story: a patient with Parkinson’s reports recurrent dizzy spells on standing and asks the pharmacist for advice before the GP appointment.

Many have been referred to autonomic or neurology clinics and face multi-week waits, creating interest in private clinics or urgent prescriptions.

Patients often request instructions on when to take doses to cover activities such as shopping or appointments and how to reduce fall risk.

Carers commonly ask about measuring blood pressure at home and spotting supine hypertension.

Older patients frequently balance fall risk against side effects such as urinary problems and scalp tingling.

What Shoppers Look For On Product Pages

Shoppers read product pages for availability, prescription status and how quickly the medicine will arrive.

They want simple dosing tables, visual dose-timing charts and printable BP logs they can take to clinic.

Clear safety callouts—“Prescription Only”, “Avoid Dose Within 4 Hours Of Bedtime”—are frequently requested by users.

Price comparisons between NHS dispensing, private prescription fees and online delivery estimates rank high in purchasing decisions.

Small comparative note: prescription medicines require a prescriber’s authority and pharmacist checks, while OTC medicines can be supplied without a prescription.

[Real data]

The example of metformin shows how INN, ATC classification, brand names and pack sizes vary by manufacturer and pack—set expectations that midodrine brands and pack sizes will likewise vary and remain prescription-only.

What Midodrine Is And When It’s Used

• Drug Class: Alpha-1 Adrenergic Agonist

• Mechanism (One Line): Increases peripheral vascular resistance to raise standing blood pressure

• Licence Status: Prescription-only (specialist initiation typical)

Active Substance & General Class

Midodrine hydrochloride is an oral alpha‑1 adrenergic agonist that works via its active metabolite to constrict peripheral blood vessels.

It is supplied as tablets for oral administration and is a prescription-only medicine in standard practice in the United Kingdom.

Typical patient profiles include those with autonomic failure from Parkinson’s disease, multiple system atrophy or diabetic autonomic neuropathy.

Primary Licensed Indication

Midodrine’s primary licensed indication is symptomatic orthostatic hypotension where non‑pharmacological measures are inadequate.

The treatment aim is to reduce symptoms such as dizziness, light-headedness and syncope on standing and thereby reduce fall risk.

Off‑Label Uses Commonly Seen In Practice

Clinicians may occasionally trial midodrine for refractory hypotension in specialist settings or specific peri‑procedural scenarios under specialist oversight.

Off‑label uses are a specialist decision and should involve careful monitoring and documented rationale.

Patients and pharmacists should expect specialist-led initiation for non-standard indications.

Mechanism Of Action

Pharmacodynamics (Practical Terms)

Midodrine is a prodrug converted to desglymidodrine, which stimulates alpha‑1 receptors on vascular smooth muscle.

Activation of these receptors produces peripheral vasoconstriction and an increase in standing systolic and diastolic blood pressure.

The practical effect is reduced pooling of blood in the legs on standing and fewer symptoms of orthostatic hypotension.

Onset, Duration & Clinical Relevance

Oral midodrine is absorbed and typically produces a measurable rise in standing blood pressure within 30–60 minutes.

The peak effect is commonly reached around 1–2 hours after a dose and the clinical duration is usually 3–4 hours.

This timing is important for patients to match dosing to periods when they anticipate being upright.

Practical Effect On Symptoms

Patients often report reduced dizziness and fewer near‑syncope episodes when doses are timed correctly before upright activity.

Avoiding late‑evening doses is important to reduce the risk of supine hypertension while asleep.

Visual timeline: Dose → Onset 30–60 mins → Peak 1–2 hrs → Duration 3–4 hrs.

Available Formulations, Strengths, Brands And Packaging

Typical Strengths & Forms Sold

Midodrine is commonly supplied as oral tablets in low and higher strengths to allow titration.

Typical tablet strengths seen in practice include 2.5 mg and 10 mg, though availability varies by supplier and region.

Pack sizes often include 28 or 56 tablets but can differ between manufacturers and wholesalers.

Brand Suppliers And Generics

Stock is predominantly generic with branded products available in some markets; local suppliers and pack sizes will vary.

Pharmacies should check manufacturer details on individual packs and confirm expiry and batch numbers at supply.

[Real data] for metformin shows how brands, strengths and pack choices vary significantly by company and country, so expect similar variability for midodrine.

Packaging, Storage & Labelling Notes

Typical labelling includes drug name, strength, dose instructions, storage advice and manufacturer contact details.

Store midodrine tablets at room temperature, protect from moisture and keep in original packaging to preserve labelling.

Child‑safety blister packs are common; make sure patients know how to read the pack for batch and expiry details.

Dosage, Administration And Timing

Typical Starting Regimens

Standard initiation often begins with a low dose such as 2.5 mg taken three times daily.

Clinicians commonly titrate to response, with maintenance doses frequently in the 2.5 mg–10 mg three times daily range.

Maximum doses are defined in specialist guidance and should be confirmed by the prescriber.

Titration & Timing For Daily Activities

Titrate slowly, increasing every 3–7 days while monitoring supine and standing blood pressure.

Arrange doses around planned upright activities; for example, take a dose 30–60 minutes before leaving the house for shopping or appointments.

Do not take a dose within 4 hours of bedtime to reduce the risk of supine hypertension overnight.

Patient dosing checklist:

• Start low and increase only as advised by prescriber.

• Time doses to cover known upright periods.

• Avoid late evening doses.

1. Titrate: Gradually increase dose to achieve symptom control.

2. Supine Hypertension: High BP while lying down; avoid late doses.

3. Orthostatic Hypotension: Drop in BP on standing that causes symptoms.

Initiation, Titration And Stopping

Who Should Initiate Midodrine

Initiation is usually performed by a specialist in autonomic disorders, cardiology or neurology, or by an experienced GP following specialist advice.

Pharmacists should verify prescriber details and ensure a documented plan for titration and monitoring is provided.

Monitoring During Titration

Ensure recent supine and standing BP readings are available before supply and after dose changes.

Review baseline cardiac history, renal function where relevant, and urinary symptoms.

Recommend review within 1–2 weeks of dose adjustment to check for supine hypertension and symptomatic benefit.

How And When To Stop The Medicine

Stop therapy if there is no symptomatic benefit after an adequate therapeutic trial (often 2–4 weeks at a therapeutic dose) or if significant adverse effects occur.

Immediate cessation is advised if the patient develops severe supine hypertension, significant urinary retention or serious allergic reaction.

A stepwise flowchart for clinic-to-pharmacy workflow: Initiation → Titration → Review → Continue/Stop.

Contraindications & Cautions

Absolute Contraindications To Check At Dispensing

Do not supply midodrine to patients with uncontrolled supine hypertension.

Avoid use in patients with severe organic heart disease, known hypersensitivity to the drug, pheochromocytoma or urinary retention where it would worsen retention.

Relative Cautions Requiring Pharmacist Discussion

Exercise caution in severe renal impairment — discuss with the prescriber for dose adjustment or specialist review.

Peripheral vascular disease and pregnancy or breastfeeding are relative cautions that need a prescriber discussion.

Older patients require closer supervision due to falls risk and increased likelihood of urinary retention.

Pharmacy Screening Checklist

• Confirm recent supine and standing blood pressure readings.

• Ask about urinary retention symptoms and urinary hesitancy.

• Review cardiovascular history and current medicines that affect blood pressure.

Drug Interactions

Major Clinically Relevant Interactions

Midodrine can add to blood pressure effects when used with other vasoconstrictors or sympathomimetics.

MAO inhibitors and some decongestants can potentiate pressor effects and require caution.

Cautions With Concurrent Antihypertensives And Sympathomimetics

When a patient is taking antihypertensive therapy, midodrine may counteract treatment and doses may need review with the prescriber.

A coordinated medication review is essential if the patient uses nitrates, beta‑blockers or high-dose sympathomimetics.

Pharmacy Counselling Points For Polypharmacy

Advise patients to bring a full medicines list to appointments and to review any drugs that can worsen orthostatic hypotension, such as tricyclic antidepressants, antipsychotics and diuretics.

Provide a short “Ask Your Prescriber” prompt: check interactions if you are on MAOIs, decongestants, strong sympathomimetics or complex antihypertensive regimens.

Side Effects, Frequency And Management

Common Adverse Effects And Their Timing

Common effects include piloerection, scalp tingling or paraesthesia and sensations of chills or goosebumps shortly after dosing.

Urinary retention and increased urinary frequency can occur, particularly in patients with underlying outlet obstruction.

Supine hypertension is a major safety concern and may develop after dosing, particularly if doses are taken late in the day.

Red Flags Requiring Urgent Review

Advise urgent medical review and immediate cessation if the patient experiences severe chest pain, marked supine hypertension, acute urinary retention or signs of anaphylaxis.

Management Tips Pharmacists Give Patients

• Measure blood pressure both supine and standing and keep a log to show the prescriber.

• Avoid doses within four hours of bedtime to reduce night‑time supine hypertension risk.

• Sit up slowly from lying or seated positions to reduce dizziness and risk of falls.

Monitoring Requirements & Follow‑Up

Baseline Checks Before Dispensing

Baseline supine and standing blood pressure readings are required before initiating midodrine and before significant dose increases.

Consider an ECG if there is a history of cardiac disease and check renal function if clinically indicated.

Document any history of urinary retention or prostatic symptoms in the patient record.

Ongoing Monitoring Schedule

Check BP within 1–2 weeks of any dose adjustment and then monthly until the dose and response are stable.

When stable, reviews can be spaced to 3–6 monthly intervals depending on clinical circumstances.

Encourage home BP monitoring with supine readings after five minutes rest and standing readings at one and three minutes.

Documentation & Shared Care

Record counselling, any supply limitations and BP readings in the patient record and communicate changes to the prescriber via EPS notes or written correspondence.

Provide patients with a downloadable BP log to bring to clinic reviews.

Use In Special Populations

Elderly Considerations & Falls Risk

Start low and titrate slowly in older patients due to increased sensitivity and higher risk of supine hypertension and urinary retention.

Watch for orthostatic symptoms and assess falls history before supply.

Renal Or Hepatic Impairment

Use with caution in renal impairment and consult the prescriber for dose adjustments if renal function is compromised.

Specialist oversight is recommended for patients with severe chronic kidney disease or significant liver disease.

Pregnancy, Breastfeeding And Driving

Limited data exist for use in pregnancy and breastfeeding and specialist risk/benefit discussion is advised before use.

Advise patients not to drive until symptomatic control has been achieved and they feel safe; warn about sudden dizziness on standing.

Provide a brief pharmacy risk stratification checklist for easy triage.

Supply, Prescribing And NHS Context

Prescription Status And MHRA/NHS Position

Midodrine is prescription-only and regulated by the MHRA in the United Kingdom.

Specialist initiation is common and regional NHS formularies may have local restrictions or prior approval requirements.

NHS Vs Private Supply, Cost Considerations

NHS supply is usually less expensive to the patient but may require prior approval or specialist recommendation depending on local commissioning rules.

Private prescriptions and online clinic routes offer faster access but at higher patient cost.

In our online pharmacy, midodrine is available without a prescription, with discreet delivery to United Kingdom in 5-14 days.

Electronic Prescribing And Online Pharmacies

The Electronic Prescription Service (EPS) improves prescription transmission and can speed dispensing at larger chains such as Boots, LloydsPharmacy and Superdrug.

Always check that online suppliers are registered and avoid unverified sources to protect patient safety and product authenticity.

Practical Pharmacy Page Elements

Mandatory Legal And Safety Information

Display clear legal status: “Prescription Only Medicine”.

State the licensed indication, key contraindications and major side effects prominently on the product page.

Include storage and appropriate disposal instructions for unused medicines.

Patient-Facing Q&A And Visuals

Offer a concise patient Q&A section answering how to take midodrine, what to expect and driving advice.

Provide printable dosing charts, a downloadable BP log and a short video or visuals on measuring supine and standing BP.

Use callouts such as “Supply Only On Prescription” and “Measure Supine And Standing Blood Pressure”.

Professional Resources And Links

Include links for professionals to the MHRA licence page, the BNF entry and local formulary notes where available.

Provide downloadable professional titration checklists and monitoring templates for clinic and pharmacy use.

Pharmacy Counselling Script & FAQ

Short Counselling Script For First Supply

Hello, I see this is for symptomatic low blood pressure when standing.

Take the tablet as prescribed, usually three times a day, and do not take any dose within four hours of bedtime.

Measure your blood pressure lying and standing and keep a log for your prescriber.

Stop and seek urgent review if you get severe chest pain, cannot pass urine, or have signs of severe hypertension while lying down.

Top 8 Patient FAQs With Short Answers

• What if I feel dizzy after a dose? — Sit or lie down and measure your blood pressure; contact your prescriber if symptoms persist.

• Can I drive? — Only when you feel your symptoms are controlled and you are safe to drive.

• What about other medicines? — Bring a full medicines list; a medication review is recommended if you take antihypertensives or sympathomimetics.

• How quickly will it work? — Often within 30–60 minutes with peak effect at 1–2 hours.

• Do I need to check my BP at home? — Yes; supine and standing readings are useful for monitoring.

• Can I take it at night? — Avoid taking doses within four hours of bedtime to reduce supine hypertension risk.

• What side effects should I expect? — Piloerection, scalp tingling, paraesthesia and possibly urinary symptoms; report severe effects immediately.

• When will my prescriber review my treatment? — Typically within 1–2 weeks of dose changes and periodically thereafter.

When To Refer Back To Prescriber Or GP

Stop supply and refer urgently for chest pain, severe supine hypertension readings, acute urinary retention or suspected allergic reaction.

Contact the prescriber if symptoms have not improved after an adequate trial or if the patient reports intolerable side effects.

Delivery Across United Kingdom